Skip to main content
OpenTrials

Clinical trial condition

Recurrent Small Cell Lung Cancer

Explore clinical trials studying Recurrent Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

20 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent Small Cell Lung Cancer trial results

Recruiting

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

NCT06681220

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations
  • VA Palo Alto Health Care System, Palo Alto, CA Palo Alto, California, United States
  • Jesse Brown VA Medical Center, Chicago, IL Chicago, Illinois, United States
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN Indianapolis, Indiana, United States
  • Robley Rex VA Medical Center, Louisville, KY Louisville, Kentucky, United States
View Trial Details
Completed

Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer

NCT01901653

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00828139

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Small Cell Lung Cancer, +9 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Arizona Cancer Center at UMC Orange Grove Tucson, Arizona, United States
  • Arizona Cancer Center at University Medical Center North Tucson, Arizona, United States
View all 257 locations
View Trial Details

Related conditions